We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

SYSMEX-EUROPA

Sysmex Europe designs and produces laboratory and hematology diagnostic solutions, including instruments, reagents, c... read more Featured Products: More products

Download Mobile App




Criteria Optimized for Microscopy Following Automated Urine Analysis

By LabMedica International staff writers
Posted on 05 Nov 2014
Print article
The Sysmex UX-2000 Fully Automated Integrated Urine Analyzer
The UX-2000 Fully Automated Integrated Urine Analyzer (Photo courtesy of Sysmex America, Inc.)
Urinalysis (UA) is one of the most requested routine tests in clinical laboratories and is very useful in screening, diagnosing, and monitoring many diseases and is not limited in scope to diseases directly involving the urinary tract.

Fully automated integrated urine analyzers analyze all physical and chemical characteristics of urine and sediments in urine on a single platform; however some formed elements present in urine, casts for example, require manual microscopic examination of the urine sample following the use of the automated urine analyzer.

Clinical pathologists at the Siriraj Hospital (Bangkok, Thailand) randomly selected 399 samples from leftover routine urinalysis specimens in order to establish the threshold of each parameter that achieved the highest efficiency. A validation set of 599 samples was then used to apply the criteria previously established. All samples were evaluated for incongruent results between the results from both components of a fully automated integrated urine analyzer for both chemical analysis (CHM) and, flow cytometry (FCM) and manual microscopic examination.

After concentration, the urine samples were examined under a CX 31 light microscope (Olympus, Tokyo, Japan). The UX-2000 fully automated integrated urine analyzer (Sysmex Corporation; Kobe, Japan) was used. This device can evaluate all physical, chemical, and sedimentary properties of urine. This instrument is made up of two analysis components. The chemical (CHM) analysis component analyzes the physical and chemical characteristics of urine. The flow cytometry (FCM) analysis component analyzes urine sedimentary content.

The investigators set 11 criteria rules for optimization. From 399 samples used in optimizing the criteria, 164 (41.1%) were positive. Among the positive samples, one (0.61%) had five parameter abnormalities, three (1.83%) had four parameter abnormalities, 15 (9.15%) had three parameter abnormalities, 63 (38.41%) had two parameter abnormalities, and 82 (50%) had one parameter abnormality. For microscopic review, they found a total of 270 occurrences from 164 samples: 48 with red blood cells (RBC), 63 with leukocytes (WBC), 10 with epithelial cells (EC), 110 with bacteria, two yeasts, five hyaline casts, 16 pathological casts, 13 with crystals, and three with small round cells (SRC).

The authors concluded that the Sysmex UX-2000 cannot completely replace microscopy, especially for abnormal urinalysis. A viable option is the combination of both the UX-2000 and manual microscopic methods to obtain the best results. This combination can minimize or eliminate error in urine preparation and can also provide flagging for alerting operators when a specimen must be confirmed by manually processing. Therefore, if the UX-2000 is used in the laboratory, it is recommended that the laboratory develop its own criteria for dictating protocols and requirements relating to manual processing. The study was published October 2, 2014, in the journal Clinica Chimica Acta.

Related Links:

Siriraj Hospital 
Olympus 
Sysmex Corporation 


Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Biological Indicator Vials
BI-O.K.
New
Piezoelectric Micropump
Disc Pump
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.